Regulatory toxicology is evolving to address these emerging issues. There is a growing emphasis on the development of alternative testing methods, such as in vitro and in silico models, to evaluate chemical safety more ethically and efficiently. Moreover, regulatory agencies are increasingly adopting risk-based approaches that consider the likelihood of exposure and potential health impacts, rather than relying solely on hazard identification.
